Catecholaminergic Crisis After a Bleeding Complication of COVID-19 Infection: A Case Report

• Main Authors: Angel Rebollo-Román, Maria R. Alhambra-Expósito, Yiraldine Herrera-Martínez, F. Leiva-Cepas, Carlos Alzas, Concepcion Muñoz-Jiménez, R. Ortega-Salas, María J. Molina-Puertas, Maria A. Gálvez-Moreno, Aura D. Herrera-Martínez
• Format: Article
• Language: English
• Published: Frontiers Media S.A. 2021-09-01
• Series: Frontiers in Endocrinology
• Subjects: bleeding; pheochromocytoma; COVID19; catecholamines; complication
• Online Access: https://www.frontiersin.org/articles/10.3389/fendo.2021.693004/full
• ISSN: 1664-2392

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents in some cases with hemostatic and thrombotic complications. Pheochromocytomas are unusual, though potentially lethal tumors. Herein we describe the first case of hemorrhage in a pheochromocytoma related to SARS-CoV-2 infection. A 62-year-old man consulted for syncope, fever, and palpitations. He was diagnosed with SARS-CoV-2 pneumonia and presented with a hemorrhage in a previously unknown adrenal mass, which resulted in a catecholaminergic crisis. Medical treatment and surgery were required for symptom control and stabilization. We hereby alert clinicians to watch for additional/unreported clinical manifestations in COVID-19 infection.